NCT03032848 is a Phase 4 clinical trial of Conjugated Estrogen in Vaginitis Atropic, sponsored by Universidade Federal do Paraná.

Who is sponsoring NCT03032848?

NCT03032848 is sponsored by Universidade Federal do Paraná.

What drugs are being tested in NCT03032848?

Interventions in NCT03032848: Conjugated Estrogen, Promestriene, Estriol, Vaginal Moisturizer - Cream.

What condition does NCT03032848 study?

NCT03032848 studies Vaginitis Atropic, Pelvic Organ Prolapse, Endometrial Hyperplasia.

Is NCT03032848 still recruiting?

NCT03032848 is currently completed. Last updated 1 May 2019.

Last reviewed 2019-05-01 · How we verify

NCT03032848

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Vaginal Estrogens Comparative Trial on Pelvic Organ Prolapse Patients

Completed Phase 4 Last updated 1 May 2019

What this trial tests

Phase 4 trial testing Conjugated Estrogen in Vaginitis Atropic in 69 participants. Completed in 26 December 2016.

Timeline

26 November 2013

Primary endpoint
20 December 2016

26 December 2016

Quick facts

Lead sponsor	Universidade Federal do Paraná
Phase	Phase 4
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	supportive care
Enrollment	69
Start date	26 November 2013
Primary completion	20 December 2016
Estimated completion	26 December 2016

Drugs / interventions tested

Conjugated Estrogen — full drug profile →
Promestriene — full drug profile →
Estriol (ESTRIOL) — full drug profile →
Vaginal Moisturizer - Cream — full drug profile →

Conditions studied

Vaginitis Atropic — all drugs for Vaginitis Atropic →
Pelvic Organ Prolapse — all drugs for Pelvic Organ Prolapse →
Endometrial Hyperplasia — all drugs for Endometrial Hyperplasia →

Sponsor

Universidade Federal do Paraná — full company profile →

Who can join

Eligibility, female only, with Vaginitis Atropic or Pelvic Organ Prolapse. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

To evaluate the difference of three vaginal estrogens creams comparative with placebo on improvement of hormonal cytology, local and systemic climacteric complaints, as well as its endometrial security.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Conjugated Estrogen

Trials testing the same drug.

NCT03663543 — Intravenous Estrogen in Kidney Transplant Study · Phase 1, PHASE2 · active not recruiting

Other Universidade Federal do Paraná trials

Trials by the same sponsor.

NCT07035522 — Ozone Therapy for Women With Endometriosis · NA · not yet recruiting
NCT05946330 — Nutritional Intervention IN Nash NON-ALCOHOLIC (NAFLD). · NA · unknown
NCT06548893 — Acceptance and Commitment Therapy (ACT) in Groups for Obsessive Compulsive Disorder: A Clinical Trial in Brazil · NA · active not recruiting
NCT03176537 — Periodontal Profile of Hypogonadic Men · Phase 4 · withdrawn
NCT03216746 — Oral Health Educational Methods in Adolescence · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03032848 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Universidade Federal do Paraná
Last refreshed: 1 May 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03032848.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing